New Japanese patent approval for Episurf Medical https://episurf.com/pressrelease/L1JlbGVhc2UvVmlld1JlbGVhc2VIdG1sL0IwNDNENzNERjFGODI5RDU=/

EPISURF MEDICAL AB: Delårsrapport 1 april - 30 juni, 2016 Episurf Medical AB Delårsrapport Delårsrapport 1 april ? 30 juni, 2016 Fortsatt tillväxt och första kliniska resultaten publicerade: Tillväxten i det andra kvartalet stöddes av att ett antal viktiga kliniska milstolpar uppnåddes Det andra kvartalet var vårt hittills starkaste avseende både implantat och skademarkerings

The total number of shares outstanding is 222,040,543, of which 971,024 are Class A-shares and 221,069,519 are Class B-shares. Episurf Medical was founded in 2009 and develops and commercialises patient-specific medical devices for the treatment of painful joint injuries. Episurf Medical’s head office is located in Stockholm and the company has a sales organisation in Europe. The share (EPIS B) is listed on Nasdaq Stockholm. Episurf Medical (Nasdaq: EPISB) today provides updates regarding the business activity during Q1 2021, reflecting impacts from the current pandemic.

Episurf news

700 likes · 19 talking about this · 3 were here. Episurf Medical is a Swedish medical technology company offering personalised solutions for cartilage lesions in the knee joint. New Japanese patent approval for Episurf Medical https://episurf.com/pressrelease/L1JlbGVhc2UvVmlld1JlbGVhc2VIdG1sL0IwNDNENzNERjFGODI5RDU=/ Episurf Medical (NASDAQ: EPIS B) is obtaining another new patent in China. The Chinese Patent Office SIPO has issued Notice of allowance for a patent related to Episurf Medical’s technology for visualisaton of joint damage. EPISURF MEDICAL AB: Delårsrapport 1 april - 30 juni, 2016 Episurf Medical AB Delårsrapport Delårsrapport 1 april ? 30 juni, 2016 Fortsatt tillväxt och första kliniska resultaten publicerade: Tillväxten i det andra kvartalet stöddes av att ett antal viktiga kliniska milstolpar uppnåddes Det andra kvartalet var vårt hittills starkaste avseende både implantat och skademarkerings New Australian patent approval for Episurf Medical http://episurf.com/news/ On February 12 th, Episurf held its 1 st Episealer Talus Skills Lab. The education in surgical technique and indications was performed by Prof. Dr. C. Niek van Dijk, MD, PhD, founder of the Amsterdam Foot & Ankle School.

News feed of Episurf Medical. Episurf Medical är ett verksamma inom medicinteknik. Bolaget driver forskning och utveckling av produkter som används för behandling av broskskador

Episurf Medical (Nasdaq: EPIS B) today announces Episurf Medical arbetar för att erbjuda människor med smärtsamma ledskador ett Episurf Medicals individanpassade implantat Episealer® och kirurgiska Episurf Medical (Nasdaq: EPIS B) meddelar idag att bolaget utsett Siaca Medical PTY Ltd (https:// news.cision.com. Episurf Medical reaches milestone of 1,000 implants. Episurf Medical (NASDAQ: EPIS B) today announces that the company has reached news.cision.com.

Eolus Vind · Eon · EOS Russia · Epiroc · Episurf · Episurf B · Epsilon · eQ Oyj Fake news · Falcon Funds · Fallskärm · FAM · Fannie Mae · Fantasma Games

AnalysisNews. The best Episurf Medical (Nasdaq: EPIS B) meddelar idag att posterpresentationen "Clinical results of a patient-specific mini-metal implant for focal… Regulatoriska 8 apr 22 Apr 21. Poster with 5-years' follow-up data presented at the 3rd World Arthroplasty Congress available. Episurf Medical (Nasdaq: EPIS B) today announces Episurf Medical arbetar för att erbjuda människor med smärtsamma ledskador ett Episurf Medicals individanpassade implantat Episealer® och kirurgiska Episurf Medical (Nasdaq: EPIS B) meddelar idag att bolaget utsett Siaca Medical PTY Ltd (https:// news.cision.com. Episurf Medical reaches milestone of 1,000 implants. Episurf Medical (NASDAQ: EPIS B) today announces that the company has reached news.cision.com.

Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. Episurf Medical: Securing SEK 140 million of new funds (Coverage paused) Even though Episurf reported their Q4’19 earnings this morning, it was shadowed by a new funding package of SEK 141 million through a direct Avstämningsdag för de teckningsoptioner av serie TO4B 2018/2023 som Episurf Medical AB (publ) ("Episurf") delar ut till sina aktieägare för att minska utspädningen i den första tranchen i den finansieringslösning som Episurf genomförde den 2 2 dagar sedan · Episurf Medical (Nasdaq: EPIS B) meddelar idag att posterpresentationen "Clinical results of a patient-specific mini-metal implant for focal cartilage lesions in the knee after 5 years" av Dr. med. Johannes Holz från Orthocentrum, Park-Klinik Manhagen, Hamburg, Tyskland, et al., vilken presenterades vid 3rd World Arthroplasty Congress, nu är tillgänglig via Episurf Medicals hemsida. New Swedish patent approval for Episurf Medical (Cision) 2020-06-22 17:45 The patent, entitled “An implant for cartilage and/or bone repair” , is within the area of joint implant materials and implant features. News feed of Episurf Medical. Episurf Medical är ett verksamma inom medicinteknik. Bolaget driver forskning och utveckling av produkter som används för behandling av broskskador På torsdag, den 7 juni 2018, inleds handeln med Episurf Medical AB:s ("Episurf") teckningsoptioner av serie TO4B 2018/2023.
På vilka sätt kan man transportera värme

Episurf Medical: Redeye provides a follow-up research note to the Q4'20 report and the 510(k) news with Episealer patellofemoral system. Publicerad: På torsdag, den 7 juni 2018, inleds handeln med Episurf Medical http://news.cision.com/se/episurf/r/handel-med-teckningsoptioner-serie-t. http://www.episurf.com/sv/news/ytterligare-preklinisk-artikel-om-episealerimplantatet-publicerad PRNewswire/ -- Episurf Medical har idag erhållit CE-märkning för bolagets PR Newswire: news distribution, targeting and monitoring.

Johannes Holz från Orthocentrum, Park-Klinik Manhagen, Hamburg, Tyskland, et al., vilken presenterades vid 3rd World Arthroplasty Congress, nu är tillgänglig via Episurf Medicals hemsida. New US patent approval for Episurf Medical 2021-04-01 10:00:00 Episurf Medical (NASDAQ: EPIS B) has received another Notice of Allowance from the United States Patent and Trademark Office (USPTO). Episurf Medical is a Swedish medical technology company, the first in the world to offer patient-specific implants and surgical instruments for the treatment of painful joint injuries. By combining expertise in implant development with patented technology for personalized design and production, Episurf Medical is able to provide people with painful joint injuries a more active and healthy life.
Fakturera eget foretag

vad är sociala skillnader
stressade binjurar behandling
bim manual archicad
förskolans värdegrundsarbete
arvsskatt i finland
bygga ut villavagn
djur med skruvade horn

Starting with a special diagnostic MRI, we first discussed the indications with the Episurf Medical team. After a positive decision, the patient was informed and the production process of the individualised implant initiated. The surgery itself is well supported by a properly designed 'Final Design' document and an Episurf representative present.

Please click on the image to see the interview with Prof. van Dijk and hear his thoughts about the new Episealer implant. Episurf Medical, Stockholm.